TRABECULAR MESHWORK PROTEINS IN GLAUCOMA
青光眼中的小梁网蛋白
基本信息
- 批准号:7659537
- 负责人:
- 金额:$ 29.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-08-01 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAllelesAuditoryBiologicalBlindnessBreedingCellsCochleaControl AnimalDepositionDisease ProgressionDown-RegulationExtracellular MatrixEyeEye diseasesFunctional disorderGenesGlaucomaGlycosaminoglycansGoalsHumanImmunohistochemistryInjection of therapeutic agentKnock-outLentivirus VectorMeasurementMessenger RNAMethodsModelingMolecularMusOptic NervePathogenesisPhysiologic Intraocular PressurePlayPrimary Open Angle GlaucomaProcessProteinsProteomicsRegulationResistanceRoleSiteSmall Interfering RNASymptomsTechniquesTestingTimeTissuesTrabecular meshwork structureViralVirus Diseasesaqueousbasecongeniceffective therapymouse modelnoveloptic nerve disorderpreventsmall hairpin RNA
项目摘要
DESCRIPTION: Glaucoma refers collectively to a group of eye diseases whose molecular basis is poorly understood. Worldwide primary open angle glaucoma (POAG) is one of the leading causes of blindness and is currently incurable. Distinguishing symptoms of POAG are increased intraocular pressure (IOP) and glaucomatous optic neuropathy. Increased resistance to aqueous outflow through the filtering trabecular meshwork (TM) tissue appears to play a key role in the onset and progression of POAG. Blockage at the level of trabecular meshwork leads to increased IOP. Proteomic and Western analyses of normal and glaucomatous TM have revealed cochlin, a secreted protein with unknown function, present exclusively in glaucomatous but not in normal TM. Subsequently we have also observed cochlin containing deposits by immunohistochemistry in glaucomatous TM. In the human cochlea, cochlin is associated with mucopolysaccharide deposits in progressive auditory dysfunction. In the TM, deposition of cochlin and mucopolysaccharides may interfere with regulation of aqueous outflow and may cause slow but progressive elevation of IOP. We have extended these studies to mice and found that cochlin levels were elevated in the DBA/2J model of glaucoma but not in control animals. The studies proposed here will use mouse models to determine the role of cochlin in IOP
elevation. The central hypothesis to be tested is that cochlin deposits in the extracellular matrix obstruct
aqueous outflow in glaucomatous TM, elevate IOP and contribute to the pathogenesis of POAG. The long-term goals of this project are to establish the mechanistic involvement of cochlin in IOP elevation and the pathogenesis of POAG, and to develop effective therapies for preventing disease progression. Our hypothesis will be tested with following specific aims: (1) To determine whether cochlin over-expression results in elevated IOP; (2) To determine whether DBA/2J mice lacking cochlin maintain normal IOP; (3) To test whether cochlin message down-regulation results in normal IOP in DBA/2J mouse. Methods will include intraocular injections, IOP measurements, viral infections, immunohistochemistry as well as other molecular and cell biological techniques.
描述:青光眼集体指的是一组分子依据的眼部疾病。 全球初级敞开角度青光眼(POAG)是失明的主要原因之一,目前是无法治愈的。 POAG的区分症状是眼内压(IOP)和青光眼神经病变增加。通过过滤小梁网(TM)组织对水流的抗性增加似乎在POAG的发作和进展中起关键作用。小梁网级的阻塞导致IOP增加。对正常和青光眼TM的蛋白质组学和西方分析表明,Cochlin是一种分泌功能的分泌蛋白,仅在青光眼中呈现,但在正常TM中不存在。随后,我们还观察到通过青光眼TM中的免疫组织化学含有沉积物的Cochlin。在人耳蜗中,科克林与逐渐听觉功能障碍中的粘多糖沉积物有关。在TM中,Cochlin和粘多糖的沉积可能会干扰水性流出的调节,并可能导致IOP的缓慢而渐进的升高。我们已经将这些研究扩展到小鼠,发现Cochlin水平在青光眼的DBA/2J模型中升高,但在对照动物中没有升高。这里提出的研究将使用小鼠模型来确定Cochlin在IOP中的作用
海拔。要测试的中心假设是细胞外基质阻塞中的科克林沉积物
青光眼TM中的水流,提升IOP并有助于POAG的发病机理。该项目的长期目标是建立科奇林在IOP升高和POAG发病机理中的机械参与,并开发有效的疗法来预防疾病进展。我们的假设将通过以下特定目的进行检验:(1)确定Cochlin过表达是否导致IOP升高; (2)确定缺乏Cochlin的DBA/2J小鼠是否保持正常IOP; (3)测试Cochlin消息下调是否导致DBA/2J鼠标中的正常IOP。方法将包括眼内注射,IOP测量,病毒感染,免疫组织化学以及其他分子和细胞生物学技术。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sanjoy K Bhattacharya其他文献
Sanjoy K Bhattacharya的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sanjoy K Bhattacharya', 18)}}的其他基金
XV Association for Ocular Pharmacology and Therapeutics Meeting (AOPT 2021)
第十五届眼部药理学和治疗协会会议(AOPT 2021)
- 批准号:
10515332 - 财政年份:2020
- 资助金额:
$ 29.71万 - 项目类别:
XV Association for Ocular Pharmacology and Therapeutics Meeting (AOPT 2021)
第十五届眼部药理学和治疗协会会议(AOPT 2021)
- 批准号:
10308550 - 财政年份:2020
- 资助金额:
$ 29.71万 - 项目类别:
Novel Targets to Promote RGC Axon Regeneration: Insights from Unique RGC Cohorts
促进 RGC 轴突再生的新目标:来自独特 RGC 队列的见解
- 批准号:
9340195 - 财政年份:2016
- 资助金额:
$ 29.71万 - 项目类别:
相似国自然基金
等位基因聚合网络模型的构建及其在叶片茸毛发育中的应用
- 批准号:32370714
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于等位基因非平衡表达的鹅掌楸属生长量杂种优势机理研究
- 批准号:32371910
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
基于人诱导多能干细胞技术研究突变等位基因特异性敲除治疗1型和2型长QT综合征
- 批准号:82300353
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACR11A不同等位基因调控番茄低温胁迫的机理解析
- 批准号:32302535
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠杆菌多粘菌素异质性耐药中phoPQ等位基因差异介导不同亚群共存的机制研究
- 批准号:82302575
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Molecular genetics of human age-related hearing loss
人类年龄相关性听力损失的分子遗传学
- 批准号:
10637870 - 财政年份:2023
- 资助金额:
$ 29.71万 - 项目类别:
Novel mechanism for sex differences in hearing loss
听力损失性别差异的新机制
- 批准号:
10659402 - 财政年份:2023
- 资助金额:
$ 29.71万 - 项目类别:
Generation and Characterization of Novel Large Animal Models of Usher Syndrome Type 3
3 型亚瑟综合症新型大型动物模型的生成和表征
- 批准号:
10706969 - 财政年份:2022
- 资助金额:
$ 29.71万 - 项目类别:
The role of Pou4f3 in age-related vestibular dysfunction
Pou4f3 在年龄相关前庭功能障碍中的作用
- 批准号:
10468947 - 财政年份:2021
- 资助金额:
$ 29.71万 - 项目类别: